Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients With Stroke

NCT05289947 is registered in ClinicalTrials.gov with Moleac Pte Ltd. as lead sponsor.

NCT NCT05289947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients With Stroke
Lead sponsor
Moleac Pte Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 21, 2023
Completion date
July 18, 2025
Enrollment
303 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, stroke sequelae, stroke, cardiovascular, stroke, cryptogenic, stroke, embolic, stroke, ischemic, strokes thrombotic